| Financial Year |
March 31 2023 |
| Monetary Funds |
507,344,124.28 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
20,152,710.70 |
| Accounts Receivable |
1,023,124,102.50 |
| Advances to Suppliers |
75,237,743.50 |
| Other Receivables |
52,854,759.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,527,163.12 |
| Inventories |
63,926,082.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
27,212,919.56 |
| Other Current Assets |
61,581,879.92 |
| Total Current Assets |
2,254,662,074.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
500,000.00 |
| Long-term Equity Investment |
238,386,837.71 |
| Investment Properties |
-- |
| Fixed Assetes |
270,010,661.36 |
| Under-construction Projects |
5,044,115.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
944,876,300.41 |
| R&D expenses |
-- |
| Goodwill |
253,531,231.19 |
| Long-Term Deferred and Prepaid Expenses |
6,157,216.77 |
| Deferred Income Tax Assets |
49,071,834.42 |
| Other Non-Current Assets |
343,073,741.46 |
| Sub-Total of Non-Current Assets |
2,222,177,455.02 |
| Total Assets |
4,476,839,529.34 |
| Short-Term Loans |
603,352,321.87 |
| Trading Financial liabilities |
-- |
| Notes Payable |
18,357,390.11 |
| Accounts Payable |
596,583,231.51 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,836,253.87 |
| Taxes Payable |
14,607,200.56 |
| Interest Payable |
1,782,307.83 |
| Dividend Payable |
3,156,117.56 |
| Other payables |
16,707,396.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
115,270,478.05 |
| Other Current Liabilities |
87,702,825.55 |
| Sub-Total of Current Liabilities |
1,550,226,228.12 |
| Long-term Loans |
699,450,286.47 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
341,884,696.52 |
| Special Payable |
-- |
| Estimatied Liabilities |
16,712,282.04 |
| Deferred Income Tax Liabilities |
30,708,751.23 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,134,055,493.62 |
| Total Liabilities |
2,684,281,721.74 |
| Paid-In Capital(Or Share Stock) |
255,319,480.00 |
| Capital Surplus |
657,251,065.52 |
| Surplus Reserve |
43,762,694.28 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
697,595,075.43 |
| Minority Stockholder's Interest |
128,271,830.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,664,285,977.17 |
| Owner's Equity（Stockholder's Equity） |
1,792,557,807.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,476,839,529.34 |
